CRCL is navigating one of its sharpest weeks since listing, with the stock down 17% and short sellers materially adding exposure into the decline.
The most striking development this week is the speed at which bearish positioning has rebuilt. Short interest jumped nearly 30% in a single week to 10.9% of free float — roughly 23.5 million shares — after a brief lull in mid-June when the figure had drifted back toward 17 million. That is a meaningful escalation for a recently listed stablecoin operator. Despite the build, the borrow market itself remains accommodating. Availability is running at 287%, meaning there are nearly three shares available to borrow for every one already lent out. Cost to borrow is only 0.49%, up modestly on the week but well within normal ranges. Nothing in the lending market suggests a squeeze is imminent. The short score has climbed to 58.2, its highest reading in the 10-day window available, reinforcing the picture of building bearish interest without the kind of borrow stress that would make it expensive to maintain. Options traders, by contrast, are not showing unusual alarm. The put/call ratio at 0.77 is marginally above its 20-day average of 0.76, with a z-score near zero — well short of the defensive extremes the 52-week range allows for.
The Street has been quick to react to the price damage. Two analyst actions landed on July 1. Compass Point upgraded the stock from Sell to Neutral while simultaneously cutting its target from $97 to $55 — a move that reads less as renewed conviction and more as an acknowledgment that the sell thesis has largely played out at current levels. Susquehanna initiated at Neutral with a $69 target, bracketing the current price closely. The mean consensus target across the coverage universe sits near $138, but that figure is heavily anchored by targets set before the recent collapse and should be treated with caution — Mizuho, for example, cut from $135 to $85 in early June, and the direction of travel across the group has been firmly lower. Twelve analysts carry Hold ratings, with no Bulls pushing targets meaningfully above current price after the recent resets. On valuation, the PE has compressed sharply, falling roughly 22 points over the past month to 47x as earnings estimates have held relatively stable while the price has fallen. The EV/EBITDA multiple at 23x has similarly contracted. Factor scores reflect the tension: EPS momentum over both 30 and 90 days ranks in the 83rd and 86th percentiles respectively, pointing to a company where underlying estimate revisions remain constructive even as the share price has de-rated hard.
The insider flow adds a cautionary note. CTO Nikhil Chandhok sold approximately $35 million worth of stock across multiple tranches on June 24 alone, at prices between $71 and $75 — levels the stock has since traded well below. The President and Chief Commercial Officer also sold on June 10. The 90-day net insider position is technically a small positive in share terms, but the recent cluster of C-suite selling near the $70-$75 level, as the stock was already in decline from its highs, is worth noting in the context of the broader price action. Marshall Wace trimmed its holding by more than 4 million shares as of the March quarter-end, while IDG Capital entities reduced exposure modestly; Vanguard and ARK added incrementally.
The next scheduled earnings event is August 10. The prior print in May produced a roughly 9% single-day decline and a further negative five-day drift. A second print in the same month showed an 8.8% one-day gain that gave way to a 2% five-day loss. The pattern across these early post-listing earnings reactions skews negative over the week following results, even when the initial day-one move is positive. With the consensus target distribution still anchored well above the current price but actively being reset lower, and short sellers rebuilding faster than at any point since late May, the August print will be scrutinised closely for evidence on whether the USDC growth trajectory can offset the rate-driven headwinds to reserve yield revenues that the bear case centres on.
See the live data behind this article on ORTEX.
Open CRCL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.